XML 41 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2

EQUITY INVESTMENTS (Notes)

12 Months Ended

Oct. 01, 2022

Equity Investments [Abstract]

Equity Investments

EQUITY INVESTMENTS

Equity investments consisted of the following as of October 1, 2022 and October 2, 2021:

			As of
(in thousands)			October 1, 2022						October 2, 2021
Non-marketable equity securities			$	5,397					$	6,388

During the year ended October 1, 2022, the Company recorded an impairment of $1.3 million on a non-marketable equity security without a readily determinable fair value. The entire amount of the investment in the non-marketable equity security was impaired due to a significant deterioration in the earnings performance of the equity investee. The impairment amount is recorded within “Selling, general and administrative expense” in the Consolidated Statement of Operations.

X

- Definition

Equity Investments [Abstract]

+ References

No definition available.

+ Details

Name:	klic_EquityInvestmentsAbstract
Namespace Prefix:	klic_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-URI https://asc.fasb.org/topic&trid=2196965

+ Details

Name:	us-gaap_EquityMethodInvestmentsDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration